Chronic thromboembolic pulmonary hypertension (CTEPH) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051110
Expand allCTEPH restriction and item codes
Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
PBS CTEPH restriction and item codes
FAQs from Service Officers
Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.
|
Item |
Description |
|
1 |
What is the maximum number of weeks approved for initial treatment? A maximum of 20 weeks can be approved for initial treatment. Patients usually commence at a lower dose and increase up to the optimal dose. However, no more than 20 weeks can be approved as then a response must be demonstrated. Q+As in OPA are used to confirm that the patient has not exceeded 20 weeks initial treatment. |
|
2 |
Can a prescriber request multiple strengths with the initial application? Yes. This is called dose titration. The lowest strength should be entered under the initial restriction code. Additional strengths can be approved under the 'balance' restriction. |